RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R2053427 | Vc-MMAD | Vc-MMAD consists the ADCs linker (Val-Cit) and potent tubulin inhibitor (MMAD). |
| R2062301 | BI-4020;BI4020 | BI-4020 is a fourth-generation, orally active, and non-covalent EGFR t |
| R2053429 | Pepstatin;Pepstatin A | Pepstatin (Pepstatin A) is a specific aspartic protease inhibitor produced by ac |
| R2053430 | Oroxylin A | Oroxylin A is a natural active flavonoid with strong anticancer effects. IC50 va |
| R2053431 | CB1-IN-1;BPRCB1184 | CB1-IN-1 (BPRCB1184) is a peripherally restricted CB1R antagonist, with Ki of 0. |
| R2053432 | Cytosporone B;Csn-B;Dothiorelone G | Cytosporone B (Csn-B; Dothiorelone G) is a naturally occurring nuclear orphan re |
| R2053433 | H-BETA-ALA-AMC TFA | H-β-Ala-AMC TFA is a substrate for aminopeptidase. |
| R2053434 | PF-04745637 | PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM for |
| R2053435 | JMS-17-2 | JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JM |
| R2053436 | GRL0617 | GRL0617 is a potent, selective and competitive noncovalent inhibitor of severe a |
| R2053437 | Apcin | Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex |
| R2053438 | CL2A-SN-38 | CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I |
| R2053439 | BMS-1001 | BMS-1001 is a potent inhibitor of PD-1/PD-L1 interaction with IC50 of 2.25 nM in |
| R2053440 | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is a drug for cancer. |
| R2053441 | FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH | AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic contr |
| R2053443 | ME0328 | ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28 |
| R2053444 | BAY-985 | BAY-985 is a highly potent, orally active and selective ATP-competitive dual inh |
| R2053445 | GSK180 | GSK180 is a selective, competitive, and potent inhibitor of kynurenine-3-monooxy |
| R2053446 | VU0238441 | VU0238441 is a potent agonist of human Muscarinic acetylcholine receptor M5 with |
| R2053447 | ML-109 | ML-109 is a potent and full thyroid stimulating hormone receptor (TSHR) agonist, |
| R2053448 | C75 | trans-C75 ((±)-C75) is an enantiomer of C75. C75 is a synthetic fatty-acid synth |
| R2053449 | NS-3-008（HCl） | NS-3-008 hydrochloride is an orally active transcriptional inhibitor of G0/G1 sw |
| R2053450 | BO-264 | BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (T |
| R2053452 | Vonafexor | Vonafexor (EYP001) is a selective FXR agonist with anti-HBV effects. |
| R2053454 | RBN-2397 | RBN-2397 is a potent, accross species and orally active NAD+ competitive inhibit |
